Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Furst

Showing results (181-190 of 251) with videos related to

Pageof 26
Sort By:
The Journal of Rheumatology|May 22, 2001
Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapiesT G Woodworth, D E Furst, V Strand, et al.
Lancet (London, England)|March 11, 1998
Microchimerism and HLA-compatible relationships of pregnancy in sclerodermaJ L Nelson, D E Furst, S Maloney, et al.
Clinical and Experimental Rheumatology|December 4, 2013
Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research InitiativeD Khanna, Ma Tan, D E Furst, et al.
Arthritis and Rheumatism|February 1, 1987
A controlled study of concurrent therapy with a nonacetylated salicylate and naproxen in rheumatoid arthritisD E Furst, K Blocka, S Cassell, et al.
The Journal of Rheumatology|February 11, 1998
Flare during drug withdrawal as a method to support efficacy in rheumatoid arthritis: amiprilose hydrochloride as an example in a double blind, randomized studyJ R Caldwell, D E Furst, A L Smith, et al.
Arthritis and Rheumatism|March 1, 1994
Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of RheumatologyJ M Kremer, G S Alarcón, R W Lightfoot, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 1995
Low-dose methotrexate may cause air trapping in patients with rheumatoid arthritisC S Dayton, D A Schwartz, N L Sprince, et al.
Clinical Rheumatology|September 8, 2019
The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA)N Barroso, T G Woodworth, D E Furst, et al.
The Journal of Rheumatology|December 1, 1992
Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysisG S Alarcón, A López-Méndez, J Walter, et al.
Clinical and Experimental Rheumatology|November 6, 2010
Differences in presentation of younger and older systemic sclerosis patients in clinical trialsH H Weng, V K Ranganath, M Oh, et al.
Pageof 26

Showing results (181-190 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Rheumatology|May 22, 2001
Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapiesT G Woodworth, D E Furst, V Strand, et al.
Lancet (London, England)|March 11, 1998
Microchimerism and HLA-compatible relationships of pregnancy in sclerodermaJ L Nelson, D E Furst, S Maloney, et al.
Clinical and Experimental Rheumatology|December 4, 2013
Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research InitiativeD Khanna, Ma Tan, D E Furst, et al.
Arthritis and Rheumatism|February 1, 1987
A controlled study of concurrent therapy with a nonacetylated salicylate and naproxen in rheumatoid arthritisD E Furst, K Blocka, S Cassell, et al.
The Journal of Rheumatology|February 11, 1998
Flare during drug withdrawal as a method to support efficacy in rheumatoid arthritis: amiprilose hydrochloride as an example in a double blind, randomized studyJ R Caldwell, D E Furst, A L Smith, et al.
Arthritis and Rheumatism|March 1, 1994
Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of RheumatologyJ M Kremer, G S Alarcón, R W Lightfoot, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 1995
Low-dose methotrexate may cause air trapping in patients with rheumatoid arthritisC S Dayton, D A Schwartz, N L Sprince, et al.
Clinical Rheumatology|September 8, 2019
The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA)N Barroso, T G Woodworth, D E Furst, et al.
The Journal of Rheumatology|December 1, 1992
Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysisG S Alarcón, A López-Méndez, J Walter, et al.
Clinical and Experimental Rheumatology|November 6, 2010
Differences in presentation of younger and older systemic sclerosis patients in clinical trialsH H Weng, V K Ranganath, M Oh, et al.
Pageof 26